Key Statistics
Market Cap$483.97M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$2.42
52W High$12.34
52W Low$2.24
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees196
Price Performance
1 Week+10.62%
3 Month+29.86%
1 Year+242.24%
FinancialsAnnual · QuiverQuant
Revenue$20.72M
Assets$339.89M
Liabilities$32.06M
Net Income$100.84M loss
About
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops candidate products using its adeno-associated virus vectors. The company is headquartered in Emeryville, California.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze FDMT with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.